Publications

Article

Big Names or Big Ideas: Do Peer-Review Panels Select the Best Science Proposals?

By: Danielle Li and Leila Agha

This paper examines the success of peer-review panels in predicting the future quality of proposed research. We construct new data to track publication, citation, and patenting outcomes associated with more than 130,000 research project (R01) grants funded by the U.S.... View Details

Keywords: Patents; Research; Entrepreneurship; Forecasting and Prediction; Innovation and Invention; Business and Government Relations; United States

Find at Harvard

Former Chairman and Chief Executive Officer of Best Buy
Author of The Heart of Business– Leadership Principles for the Next Era of Capitalism

Hubert Joly is a senior lecturer in the General Management unit and... View Details

William C. Vrattos

Bill Vrattos is a Senior Lecturer at the Harvard Business School, where he teaches Investment Strategies, a course on public market investing in the elective curriculum. He also co-teaches Private Equity Projects and Ecosystems, where he mentors student groups on... View Details

Teaching

Overview

By: John D. Macomber

Teaching and research interests center around the matching of private and instituional capital into large public infrastructure and resilience projects that shape the future of cities and urban environments around the world. The world's population is increaslingly... View Details

February 2022
Case

Paul Polman

By: Elizabeth A. Keenan, Youngme Moon and Susie Ma

Over his 40-year career, Paul Polman had led some of the world’s largest consumer goods companies, making his biggest mark as CEO of Unilever—a multi-national corporation that produced everything from soap to soup. Polman was also well-regarded as a leader in corporate... View Details

Keywords: Marketing; Brands and Branding; Marketing Communications; Marketing Strategy; Leadership; Corporate Accountability; Personal Development and Career; Corporate Social Responsibility and Impact; Ethics; Values and Beliefs; Social Issues; Philanthropy and Charitable Giving

Ashish Nanda is Senior Lecturer and C. Roland Christensen Distinguished Management Educator at Harvard Business School. From 2018 to 2021, he was course head for the MBA Required Curriculum course in Strategy. Beginning in 2022, he is teaching an MBA Elective... View Details

14 Dec 2015
News

What Happens When Zambian Schoolgirls Receive Negotiation Training

Teaching Interest

Africa: Building Cities: Immersive Field Course

By: John D. Macomber

This second year elective takes students into the field to assess and report on the opprtunities in the next decade for the private finance and delivery of public infrastructure in the Global South. In January of 2016 and 2017 the cities studied were Addis Ababa,... View Details

Keywords: Cities; Urbanization; Economic Development; Infrastructure; Sustainability; Africa; Latin America; Peru; Argentina; Ethiopia; Tanzania

January 2024
Article

Cost of Exempting Sole Orphan Drugs from Medicare Negotiation

By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome

Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details

Keywords: Health Care and Treatment; Insurance; Price; Health Industry

Find at Harvard

11 Jul 2006
First Look

First Look: July 11, 2006

Working PapersGlobalizing the Beauty Business Before 1980 Geoffrey G. Jones This working paper examines the globalization of the beauty industry before 1980. This industry, which had emerged in its modern form in the United States... View Details

Keywords: Sean Silverthorne

July 2021
Supplement

Adaptive Platform Trials: The Clinical Trial of the Future? (C)

By: Ariel D. Stern and Sarah Mehta

This (C) case provides an update on the work of the Global Coalition for Adaptive Research (GCAR) and also illustrates how adaptive platform trials can nimbly respond to a global pandemic. View Details

Keywords: Clinical Trials; Drug Trials; Drug Testing; Cancer Trials; Glioblastoma; Platform Trials; Adaptive Trials; Adaptive Platform Trials; Health Testing and Trials; Health Care and Treatment; Business Strategy; Health Industry; United States

October 2020
Teaching Plan

Merck: COVID-19 Vaccines

By: Willy C. Shih

COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,... View Details

Keywords: Vaccines; Health Pandemics; Health Testing and Trials; Innovation and Management; Innovation Strategy; Research and Development; Business Strategy; Pharmaceutical Industry; United States

Rosabeth Moss Kanter holds the Ernest L. Arbuckle Professorship at Harvard Business School, specializing in strategy, innovation, and leadership for change. Her strategic and practical insights guide leaders worldwide through teaching, writing, and direct... View Details

August 2012 (Revised May 2013)
Case

Milwaukee (A): Making of a World Water Hub

By: Rosabeth Moss Kanter and Matthew Bird

Starting in 2007 Milwaukee leaders from different areas (large established companies, civic organizations, public sector, academia, and entrepreneurs) negotiated a path for converting the region into a global water hub to address economic and environmental concerns.... View Details

Keywords: Change Management; Growth Management; Business or Company Management; Leading Change; Wisconsin

September 2022
Article

Energy Innovation Funding and Institutions in Major Economies

By: Jonas Meckling, Clara Galeazzi, Esther Shears, Tong Xu and Laura Diaz Anadon

Accelerating energy innovation for decarbonization hinges on public investment in research, development and demonstration (RD&D). Here we examine the evolution and variation of public energy RD&D funding and institutions and associated drivers across eight major... View Details

Keywords: Research and Development; Innovation and Invention; Energy Policy; Government Legislation; Energy Sources

Register to Read

20 Dec 2016
First Look

December 20, 2016

to creating your own model. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=52002 January 2017 Journal of Public Economics Innovation Under Regulatory Uncertainty: Evidence from Medical Technology By: Stern, Ariel Dora... View Details

Keywords: Carmen Nobel

September 2009 (Revised May 2011)
Case

Acumen Fund: Measurement in Impact Investing (A)

By: Alnoor Ebrahim and V. Kasturi Rangan

Acumen Fund is a global venture capital firm with a dual purpose: it looks for a return on its investments, and it also seeks entrepreneurial solutions to global poverty. This case examines Acumen's new projects in Kenya. The organization's investment committee and its... View Details

Keywords: Decision Choices and Conditions; Venture Capital; Investment Return; Philanthropy and Charitable Giving; Risk Management; Corporate Social Responsibility and Impact; Business and Government Relations; Social Enterprise; Financial Services Industry; Kenya

26 Sep 2011
HBS Case

HBS Cases: Lady Gaga

A&M Vice Chairman Steve Berman, Live Nation's global touring CEO Arthur Fogel, William Morris Endeavor agent Marc Geiger, and producer Vincent Herbert. Go Big or Go Home? In the autumn of 2009, Lady Gaga was set to go on the road with... View Details

Keywords: by Carmen Nobel; Entertainment & Recreation; Music

May 2011 (Revised March 2013)
Supplement

Marshall & Gordon: Designing an Effective Compensation System (B)

By: Heidi K. Gardner and Kerry Herman

CEO Kelly Browne wrestles with the design and roll-out of a new compensation system to promote the collaboration necessary for supporting her firm's new strategy. Marshall Gordon International, a global public relations (PR) firm, has recently expanded its service... View Details

Keywords: Globalization; Executive Compensation; Management; Organizational Culture; Performance; Groups and Teams; Behavior; Corporate Strategy; System